Follow the people · Insider

RT

Rahsaan Thompson

Insider · Chief Legal & Compliance · ZVRA

Rahsaan Thompson files insider transactions with the SEC as a chief legal & compliance of Zevra Therapeutics (ZVRA). We hold 4 disclosed purchases and sales filed since 15 May 2020, 2 of them in the last 90 days.

  • Files forZVRA
  • Disclosed buys and sells4 in all, 2 in the last 90 days
  • Last disclosure17 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 June 202414 August 2026Chief Legal & Compliance · Zevra Therapeutics (ZVRA)21 Form 4 lines · source: SEC Form 4
  • Filed 10 October 202224 February 2023Chief Legal Officer · Lyell Immunopharma (LYEL)2 Form 4 lines · source: SEC Form 4
  • Filed 13 May 202031 January 2022EVP and General Counsel · Gritstone bio (GRTS)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

28 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.